Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis.

导出原文传递

翻译打印收藏纠错

作者： Azusa,Taniguchi ^[1] ; Nobuyoshi,Kittaka ^[2] ; Haruka,Kanaoka ^[1] ; Satomi,Nakajima ^[1] ; Yuri,Oyama ^[1] ; Yukiko,Seto ^[1] ; A I,Soma ^[1] ; Hiroki,Kusama ^[1] ; Noriyuki,Watanabe ^[1] ; Saki,Matsui ^[1] ; Minako,Nishio ^[3] ; Fumie,Fujisawa ^[3] ; Takahiro,Nakayama ^[1]

作者单位： Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan. ^[1] Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan; nobuyoshi.kittaka@oici.jp kittaka-no@osakah.johas.go.jp. ^[2] Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan. ^[3]

关键词 Abemaciclib aromatase inhibitor breast cancer liver injury risk factor

主题词人类(Humans);老年人(Aged);女(雌)性(Female);乳腺肿瘤(Breast Neoplasms);回顾性研究(Retrospective Studies);前瞻性研究(Prospective Studies);芳香酶抑制剂(Aromatase Inhibitors)

DOI 10.21873/anticanres.16114

PMID 36456126

发布时间 2022-12-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交